This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Ms. Tsafrir is an expert in economics, accounting and banking. She is an independent consultant providing financial consulting to organizations and individuals, as well as a director in several enterprises, including Altusher Shacham Investments, Kadimastam and the Mediterranean Towers.
Ms. Tsafrir worked at Discount Bank for 3 years as a Business Development Manager, and at Bank Leumi for 15 years in a variety of roles, establishing and managing the branch of capital market
customers, and serving as a commercial banking manager and a macro financial expert.
Ms. Tsafrir earned a BA (cum laude) in Finance and an MA in Finance, both from Tel Aviv University.